Home
Mission: Genome Diagnostics aims to offer accurate diagnostic tools to facilitate donor/recipient matching, ultimately leading to higher success rates of bone-marrow, cord blood and stem cell transplantations.
GenDx ISO 13485:2003 Certified
 We are very happy to announce that Genome Diagnostics B.V. meets the ISO 13485:2003 requirements as of March 1, 2009.
More information can be found here.
SBTengine CE IVD Marked
We are happy to announce that SBTengine is CE IVD Marked as of May 7, 2009.
More information can be found here.
New meetings in 2009
The Teaching Session will be organized at Monday November 2nd 2009 in San Francisco, USA.
More information can be found here!
Annual ASHI meeting will start after the teaching session.
For transplantation there is a high need for a tissue match between patient and the donor. Without a full match there is an increased chance that the transplanted organ or bone marrow maybe rejected. Besides many immediate negative effects for the patient, a failed transplantation also affects future transplantation, as the patient may become highly sensitized.
Tissue typing maybe carried out by various methods. The preferred method of choice is dependent on several factors like location, access to technology, expertise of personnel and allocated budget. In the UMC Utrecht researchers have developed a strategy that allows typing of the donors and patient at the highest resolution.
This Sequencing Based Strategy (SBT) has become the gold standard. However, proper implementation is delayed by the availability of adequate software, reliable reagents and proper training and support.
GenDx offers a comprehensive solution that is already adopted by a significant number of laboratories world wide. |
